Adam Morgan Insider Profile

Adam Morgan, Director at Heron Therapeutics, holds 7.04M shares in Heron Therapeutics (Ticker: HRTX), holds 13.61M shares in Alimera (Ticker: ALIM).
Adam Morgan

Adam Morgan
Heron Therapeutics (HRTX)

Ranked #16,027 out of 98,501 Corporate Insiders

Profitable Transactions

3 out of 3 Profitable Transactions

Average Return

Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

A breakdown of Adam Morgan's holdings

Insider Roles

Director, Ten Percent Owner
Heron Therapeutics
Roles that Adam Morgan holds in companies

Most Profitable Insider Trade

Heron Therapeutics
Rating:Informative Buy
Date:Jul 25, 2023 - Today
The most profitable trade made by Adam Morgan

Adam Morgan's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Heron Therapeutics
Jan 19, 2024
Uninformative Buy
Aug 17, 2023
Director, Ten Percent Owner
Informative Buy
List of latest transactions for each holding click on a transaction to see Adam Morgan's performance on stock

Adam Morgan insider profile FAQ

What is the percentage of profitable transactions made by Adam Morgan?
The percentage of profitable transactions made by Adam Morgan is 100%.
    What is the average return per transaction made by Adam Morgan?
    The average return per transaction made by Adam Morgan is 49.90%.
      What stocks does Adam Morgan hold?
      Adam Morgan holds: HRTX, ALIM stocks.
        What was Adam Morgan’s latest transaction?
        Adam Morgan latest transaction was an Uninformative Buy of ―.
          What was Adam Morgan's most profitable transaction?
          Adam Morgan’s most profitable transaction was an Informative Buy of HRTX stock on July 25, 2023. The return on the trade was 92.70%.
            What is Adam Morgan's role in Heron Therapeutics?
            Adam Morgan's role in Heron Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.